SLI
2.143,62
PKT
-9,10
PKT
-0,42
%
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 14.01.26 | UBS Buy | Deutsche Bank AG | |
| 14.01.26 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 13.01.26 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 13.01.26 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 13.01.26 | Roche Neutral | JP Morgan Chase & Co. | |
| 13.01.26 | Richemont Buy | Jefferies & Company Inc. | |
| 12.01.26 | Nestlé Hold | Deutsche Bank AG | |
| 12.01.26 | UBS Underweight | Barclays Capital | |
| 12.01.26 | UBS Overweight | JP Morgan Chase & Co. | |
| 09.01.26 | Roche Outperform | Bernstein Research | |
| 09.01.26 | Nestlé Neutral | UBS AG | |
| 08.01.26 | Nestlé Neutral | JP Morgan Chase & Co. | |
| 08.01.26 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.01.26 | Nestlé Equal Weight | Barclays Capital | |
| 08.01.26 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.01.26 | Zurich Insurance Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.01.26 | Roche Neutral | JP Morgan Chase & Co. | |
| 08.01.26 | UBS Outperform | RBC Capital Markets | |
| 08.01.26 | ams-OSRAM Equal Weight | Barclays Capital | |
| 07.01.26 | Nestlé Hold | Jefferies & Company Inc. | |
| 07.01.26 | Nestlé Equal Weight | Barclays Capital | |
| 07.01.26 | Nestlé Market-Perform | Bernstein Research | |
| 07.01.26 | Zurich Insurance Hold | Deutsche Bank AG | |
| 07.01.26 | Novartis Equal Weight | Barclays Capital | |
| 07.01.26 | Roche Overweight | Barclays Capital | |
| 07.01.26 | Nestlé Hold | Jefferies & Company Inc. | |
| 07.01.26 | ABB (Asea Brown Boveri) Market-Perform | Bernstein Research | |
| 06.01.26 | ABB (Asea Brown Boveri) Underweight | Barclays Capital | |
| 06.01.26 | Givaudan Equal-weight | Morgan Stanley | |
| 05.01.26 | Swiss Re Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.01.26 | Swiss Re Underperform | RBC Capital Markets | |
| 05.01.26 | Roche Neutral | JP Morgan Chase & Co. | |
| 05.01.26 | Novartis Overweight | JP Morgan Chase & Co. | |
| 05.01.26 | Richemont Buy | UBS AG | |
| 30.12.25 | Nestlé Neutral | JP Morgan Chase & Co. | |
| 30.12.25 | Nestlé Market-Perform | Bernstein Research | |
| 23.12.25 | Novartis Overweight | JP Morgan Chase & Co. | |
| 23.12.25 | Roche Neutral | JP Morgan Chase & Co. | |
| 18.12.25 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 18.12.25 | Nestlé Market-Perform | Bernstein Research |